Mapp Biopharma Scientists Try To Stop Another Deadly Virus
An experimental drug could offer a new weapon against the virus that causes Argentine hemorrhagic fever -- a potentially fatal infection that is considered a "bioterror" threat.
The findings are based on lab studies of guinea pigs. And researchers said it's not clear when the treatment might advance to human trials.
The findings are based on lab studies of guinea pigs. And researchers said it's not clear when the treatment might advance to human trials.